DekaBank Deutsche Girozentrale
AMRX icon

DekaBank Deutsche Girozentrale’s Amneal Pharmaceuticals AMRX Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6,655
Closed -$42K – 1433
2024
Q2 		$42K Buy
+6,655
New +$42.2K ﹤0.01% 1396
2019
Q1 		– Sell
-5,507
Closed -$77K – 1193
2018
Q4 		$77K Buy
5,507
+995
+22% +$17.9K ﹤0.01% 1097
2018
Q3 		$101K Buy
+4,512
New +$95K ﹤0.01% 1142

Other funds holding AMRX

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

DekaBank Deutsche Girozentrale's AMRX Position: Q3 2024 in Review

DekaBank Deutsche Girozentrale sold out of Amneal Pharmaceuticals (AMRX) in Q3 2024, closing a stake of 6,655 shares — an estimated $42K sold.

DekaBank Deutsche Girozentrale first reported a position in AMRX in Q3 2018 and held it in 3 quarters. The position peaked at $101K in Q3 2018. 182 funds tracked by Wall St. Rank hold AMRX as of Q3 2024.

  • DekaBank Deutsche Girozentrale reported no remaining Amneal Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 6,655 Amneal Pharmaceuticals shares in Q3 2024, an estimated $42K.
  • DekaBank Deutsche Girozentrale first reported a position in Amneal Pharmaceuticals in Q3 2018 and held it in 3 quarters.
  • DekaBank Deutsche Girozentrale's Amneal Pharmaceuticals position peaked at $101K in Q3 2018.
  • 182 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2024.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2024, filed 24 Oct 2024.